vs
Side-by-side financial comparison of IM Cannabis Corp. (IMCC) and USANA HEALTH SCIENCES INC (USNA). Click either name above to swap in a different company.
USANA HEALTH SCIENCES INC is the larger business by last-quarter revenue ($213.7M vs $10.1K, roughly 21083.2× IM Cannabis Corp.). USANA HEALTH SCIENCES INC runs the higher net margin — -3.1% vs -7.8%, a 4.7% gap on every dollar of revenue. IM Cannabis Corp. produced more free cash flow last quarter ($2.2K vs $-5.2M).
IM Cannabis Corp is a global cannabis enterprise focused on the cultivation, production, distribution and retail of medical and adult-use cannabis products. It runs business across core markets including North America, the European Union and Israel, offering branded cannabis goods, wellness derivatives and related consumer products to medical patients and recreational users.
Usana Health Sciences, Inc., or USANA, is an American multi-level marketing company based in Salt Lake City, Utah. As of 2021, Usana was the 14th largest direct-selling company in the world by revenue. The company manufactures most of its nutritional products, dietary supplements, and skincare products at a Salt Lake City facility. Its products are sold in 24 countries via a network of independent distributors.
IMCC vs USNA — Head-to-Head
Income Statement — Q3 2025 vs Q3 2026
| Metric | | |
|---|---|---|
| Revenue | $10.1K | $213.7M |
| Net Profit | $-790 | $-6.5M |
| Gross Margin | 22.7% | 77.2% |
| Operating Margin | -6.9% | 0.6% |
| Net Margin | -7.8% | -3.1% |
| Revenue YoY | — | 6.7% |
| Net Profit YoY | — | -161.5% |
| EPS (diluted) | — | $-0.36 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q3 25 | $10.1K | $213.7M | ||
| Q2 25 | $8.8K | $235.8M | ||
| Q1 25 | — | $249.5M | ||
| Q4 24 | $11.8K | $213.6M | ||
| Q3 24 | $9.0K | $200.2M | ||
| Q2 24 | $10.8M | $212.9M | ||
| Q1 24 | $9.1K | $227.8M | ||
| Q4 23 | — | $221.1M |
| Q3 25 | $-790 | $-6.5M | ||
| Q2 25 | $-4.4K | $9.7M | ||
| Q1 25 | — | $9.4M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $-1.6K | $10.6M | ||
| Q2 24 | $-2.5M | $10.4M | ||
| Q1 24 | — | $16.5M | ||
| Q4 23 | — | — |
| Q3 25 | 22.7% | 77.2% | ||
| Q2 25 | 14.7% | 78.7% | ||
| Q1 25 | — | 79.0% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | 21.4% | 80.4% | ||
| Q2 24 | 5.7% | 81.1% | ||
| Q1 24 | 23.2% | 81.1% | ||
| Q4 23 | — | 80.9% |
| Q3 25 | -6.9% | 0.6% | ||
| Q2 25 | -46.7% | 7.1% | ||
| Q1 25 | — | 6.3% | ||
| Q4 24 | -236.7% | 3.8% | ||
| Q3 24 | 18.3% | 7.8% | ||
| Q2 24 | -19.5% | 8.4% | ||
| Q1 24 | 28.9% | 10.8% | ||
| Q4 23 | — | 11.0% |
| Q3 25 | -7.8% | -3.1% | ||
| Q2 25 | -49.9% | 4.1% | ||
| Q1 25 | — | 3.8% | ||
| Q4 24 | — | 2.1% | ||
| Q3 24 | -17.3% | 5.3% | ||
| Q2 24 | -23.4% | 4.9% | ||
| Q1 24 | — | 7.3% | ||
| Q4 23 | — | — |
| Q3 25 | — | $-0.36 | ||
| Q2 25 | — | $0.52 | ||
| Q1 25 | — | $0.49 | ||
| Q4 24 | — | $0.23 | ||
| Q3 24 | — | $0.56 | ||
| Q2 24 | — | $0.54 | ||
| Q1 24 | — | $0.86 | ||
| Q4 23 | — | $0.87 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $145.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | — | $528.1M |
| Total Assets | — | $726.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | — | $145.3M | ||
| Q2 25 | — | $151.3M | ||
| Q1 25 | — | $179.6M | ||
| Q4 24 | $630.0K | $181.8M | ||
| Q3 24 | — | $364.9M | ||
| Q2 24 | $511.0K | $332.4M | ||
| Q1 24 | — | $328.3M | ||
| Q4 23 | — | $330.4M |
| Q3 25 | — | $528.1M | ||
| Q2 25 | — | $531.1M | ||
| Q1 25 | — | $529.8M | ||
| Q4 24 | $2.3M | $532.1M | ||
| Q3 24 | — | $533.1M | ||
| Q2 24 | $4.0M | $512.2M | ||
| Q1 24 | — | $500.0M | ||
| Q4 23 | — | $497.2M |
| Q3 25 | — | $726.6M | ||
| Q2 25 | — | $734.5M | ||
| Q1 25 | — | $746.6M | ||
| Q4 24 | $28.6M | $748.2M | ||
| Q3 24 | — | $671.3M | ||
| Q2 24 | $29.4M | $631.4M | ||
| Q1 24 | — | $629.3M | ||
| Q4 23 | — | $632.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.3K | $-2.0M |
| Free Cash FlowOCF − Capex | $2.2K | $-5.2M |
| FCF MarginFCF / Revenue | 21.6% | -2.4% |
| Capex IntensityCapex / Revenue | 0.9% | 1.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $18.7M |
8-quarter trend — quarters aligned by calendar period.
| Q3 25 | $2.3K | $-2.0M | ||
| Q2 25 | — | $12.2M | ||
| Q1 25 | — | $15.5M | ||
| Q4 24 | $-786.2K | $5.8M | ||
| Q3 24 | — | $29.5M | ||
| Q2 24 | — | $8.0M | ||
| Q1 24 | $-4.4K | $17.7M | ||
| Q4 23 | — | $26.0M |
| Q3 25 | $2.2K | $-5.2M | ||
| Q2 25 | — | $7.2M | ||
| Q1 25 | — | $12.7M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $27.1M | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | $-4.7K | $14.5M | ||
| Q4 23 | — | $18.7M |
| Q3 25 | 21.6% | -2.4% | ||
| Q2 25 | — | 3.0% | ||
| Q1 25 | — | 5.1% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 13.6% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | -51.7% | 6.4% | ||
| Q4 23 | — | 8.5% |
| Q3 25 | 0.9% | 1.5% | ||
| Q2 25 | — | 2.1% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 0.8% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 1.3% | ||
| Q1 24 | 3.3% | 1.4% | ||
| Q4 23 | — | 3.3% |
| Q3 25 | — | — | ||
| Q2 25 | — | 1.27× | ||
| Q1 25 | — | 1.65× | ||
| Q4 24 | — | 1.29× | ||
| Q3 24 | — | 2.78× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.07× | ||
| Q4 23 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IMCC
Segment breakdown not available.
USNA
| Direct Selling | $175.8M | 82% |
| Hiya | $30.8M | 14% |
| All Other | $7.0M | 3% |
